Reston ebolavirus

Reston ebolavirus
Name	Reston ebolavirus
Virus group	Filoviridae
Genus	Ebolavirus
Species	Reston ebolavirus
Synonyms	Reston virus

Reston ebolavirus is a species of filovirus first identified in 1989 associated with captive primates in the United States; it is notable for apparent nonpathogenic infections in humans and pathogenicity in certain nonhuman primates and swine. It belongs to the family Filoviridae and sits within a taxonomic framework studied by virologists, epidemiologists, and public health agencies during zoonotic events. The species has influenced laboratory biosafety practices at institutions such as the Centers for Disease Control and Prevention, the World Health Organization, and academic centers focusing on emerging infectious diseases.

Taxonomy and virology

Reston ebolavirus is classified within the family Filoviridae alongside genera that include Marburgvirus and other ebolavirus species; taxonomic decisions are guided by the International Committee on Taxonomy of Viruses and researchers at institutions like the National Institutes of Health and the Pasteur Institute. Molecular characterization relies on genome sequencing techniques developed by laboratories at universities such as Johns Hopkins University, Harvard University, and the University of Oxford, employing phylogenetic methods used in studies of severe acute respiratory syndrome coronavirus and influenza A virus. The virion is filamentous and enveloped, with a negative-sense single-stranded RNA genome encoding proteins analogous to those characterized in studies led by teams at the Scripps Research Institute and the Broad Institute. Structural biology work at institutes like the Max Planck Society and the European Molecular Biology Laboratory has elucidated glycoprotein conformations that are targets of neutralizing antibodies investigated by groups at the Rockefeller University and the Karolinska Institutet.

History and outbreaks

The original discovery in 1989 involved a primate shipment traced from a breeding facility in the Philippines to quarantine facilities in Reston, Virginia, prompting investigations by the United States Army Medical Research Institute of Infectious Diseases and the Centers for Disease Control and Prevention. Subsequent detections included events in the Philippines, Italy, and the United States, involving organizations such as the Food and Drug Administration, Department of Agriculture, and the University of the Philippines. Notable investigations involved collaborative teams from the Armed Forces Research Institute of Medical Sciences, the Walter Reed Army Institute of Research, and veterans of outbreak responses with experience from the Ebola virus disease epidemics that engaged Médecins Sans Frontières and the World Health Organization. Media coverage and scientific commentary appeared in outlets and journals linked to Columbia University, Stanford University, and the London School of Hygiene & Tropical Medicine during follow-up surveillance in the early 2000s and later serosurveys led by the University of the Philippines Manila and the Research Institute for Tropical Medicine.

Transmission and host range

Field and experimental studies implicate fruit bats as reservoir candidates, echoing reservoir research conducted at the Smithsonian Institution, the University of Illinois, and the University of Liverpool, and drawing on methodologies used in Nipah virus and Hendra virus ecology research by CSIRO and the Commonwealth Scientific organizations. Domesticated swine infections documented in the Philippines involved collaborations among veterinary services at the Department of Agriculture, the University of Georgia, and the University of Pennsylvania. Nonhuman primate outbreaks implicated facilities operated by primate breeding centers and biomedical suppliers, with involvement from ethics committees at institutions such as the National Institutes of Health and regulatory oversight bodies like the European Centre for Disease Prevention and Control. Human exposure investigations have been coordinated by occupational health groups at the Occupational Safety and Health Administration and by hospital infection control teams at tertiary centers like Massachusetts General Hospital and the Mayo Clinic.

Pathogenesis and clinical features

Experimental infections in macaques studied at primate research centers including the New England Primate Research Center and the Yerkes National Primate Research Center produced hemorrhagic disease and systemic manifestations similar to disease models developed at the University of Texas Medical Branch and the University of California, Davis. In contrast, serologic surveys among laboratory workers and abattoir personnel in the Philippines conducted by the Research Institute for Tropical Medicine and academic collaborators at the University of Santo Tomas detected evidence of asymptomatic or mild infections in humans, prompting clinical guidance from professional societies such as the Infectious Diseases Society of America and the American Society for Microbiology. Comparative pathology work published by groups at the Centers for Disease Control and Prevention and the Armed Forces Research Institute of Medical Sciences has examined tissue tropism, immune response modulation, and coagulopathy features paralleling investigations into dengue virus and Lassa fever pathogenesis at institutions like the Baylor College of Medicine.

Diagnosis and laboratory biosafety

Diagnostic approaches include real-time RT-PCR assays validated by the Centers for Disease Control and Prevention, enzyme-linked immunosorbent assays developed in collaborations with academic laboratories at Emory University and the University of Washington, and viral isolation performed in high-containment laboratories following protocols from the World Health Organization and the European Commission. Laboratory containment recommendations draw on biosafety frameworks from the National Institutes of Health, the Centers for Disease Control and Prevention, and the Select Agent Program overseen by the Federal Select Agent Program, with high-containment training provided by institutions such as the United States Army Medical Research Institute of Infectious Diseases and the Public Health Agency of Canada. Biosafety level assignments and decontamination standards reference guidelines used in handling other high-consequence pathogens like Nipah virus and SARS-CoV.

Prevention, control, and public health response

Prevention strategies have involved surveillance programs coordinated by national public health agencies including the Department of Health of the Philippines, the Centers for Disease Control and Prevention, and the World Health Organization, as well as veterinary public health actions led by the Food and Agriculture Organization and national ministries of agriculture. Infection prevention in laboratory and clinical settings follows protocols from institutions such as Johns Hopkins Hospital, Cleveland Clinic, and the University of Tokyo Hospital, while outbreak communication and risk assessment engage organizations like Médecins Sans Frontières, the European Centre for Disease Prevention and Control, and the Global Outbreak Alert and Response Network. Research into vaccine platforms and monoclonal antibody therapeutics has involved partnerships among biotech companies, academic consortia including the Vaccine Research Center, and funding bodies such as the National Institutes of Health and the Wellcome Trust.

Category:Filoviridae